August 27, 2014 8:40 PM ET

Capital Markets

Company Overview of CMEA Capital

Executive Profile

James W. Larrick Ph.D.

Chairman of Scientific Advisory Board and Consultant, KaloBios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 9 different industries.

See Board Relationships
----

Background

Dr. James W. Larrick, Ph.D., known as Jim, is the Co-Founder of Galaxy Biotech, LLC. Dr. Larrick serves as a Consultant and Chairman of Scientific Advisory Board at KaloBios Pharmaceuticals, Inc. Since 1991, he has founded or co-founded 10 companies, including Planet Biotechnology Inc., TargetQuest LLC, Galaxy Biotech, PanGenetics B.V., PanResearch, Inc., Neuromolecular Inc., and KaloBios, Inc. He founded Target Quest, B.V. He co-founded Adamas Pharmaceuticals, Inc. ...

Corporate Headquarters

1 Letterman Drive
San Francisco, California 94129

United States

Phone: 415-352-1520
Fax: 415-352-1524

Board Members Memberships

Former Director
Director, Co-Chairman of Bio Screening Committee and Biotech Investment Committee

Education

Post-Doctoral Training
The Leland Stanford Junior University
PhD
Duke University Medical Center
MD
Duke University Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CMEA Capital, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.